93 related articles for article (PubMed ID: 20303996)
21. Differential responses in CBF and CBV to cocaine as measured by fMRI: implications for pharmacological MRI signals derived oxygen metabolism assessment.
Luo F; Schmidt KF; Fox GB; Ferris CF
J Psychiatr Res; 2009 Aug; 43(12):1018-24. PubMed ID: 19135215
[TBL] [Abstract][Full Text] [Related]
22. Acetylcholinesterase inhibition increases in vivo N-(2-[18F]fluoroethyl)-4-piperidyl benzilate binding to muscarinic acetylcholine receptors.
Skaddan MB; Kilbourn MR; Snyder SE; Sherman PS
J Cereb Blood Flow Metab; 2001 Feb; 21(2):144-8. PubMed ID: 11176279
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotropin-releasing hormone in membranes of rat frontal cortex.
Onali P; Olianas MC
J Pharmacol Exp Ther; 1998 Aug; 286(2):753-9. PubMed ID: 9694930
[TBL] [Abstract][Full Text] [Related]
24. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
Waelbroeck M; Gillard M; Robberecht P; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):91-9. PubMed ID: 3600616
[TBL] [Abstract][Full Text] [Related]
25. Milameline (CI-979/RU35926): a muscarinic receptor agonist with cognition-activating properties: biochemical and in vivo characterization.
Schwarz RD; Callahan MJ; Coughenour LL; Dickerson MR; Kinsora JJ; Lipinski WJ; Raby CA; Spencer CJ; Tecle H
J Pharmacol Exp Ther; 1999 Nov; 291(2):812-22. PubMed ID: 10525104
[TBL] [Abstract][Full Text] [Related]
26. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models.
Chandra JN; Malviya M; Sadashiva CT; Subhash MN; Rangappa KS
Neurochem Int; 2008 Feb; 52(3):376-83. PubMed ID: 17719699
[TBL] [Abstract][Full Text] [Related]
27. Probing peripheral and central cholinergic system responses.
Naranjo CA; Fourie J; Herrmann N; Lanctôt KL; Birt C; Yau KK
J Psychiatry Neurosci; 2000 Sep; 25(4):325-36. PubMed ID: 11022397
[TBL] [Abstract][Full Text] [Related]
28. Muscarinic acetylcholine neurotransmission enhances the late-phase of long-term potentiation in the hippocampal-prefrontal cortex pathway of rats in vivo: a possible involvement of monoaminergic systems.
Lopes Aguiar C; Romcy-Pereira RN; Escorsim Szawka R; Galvis-Alonso OY; Anselmo-Franci JA; Pereira Leite J
Neuroscience; 2008 Jun; 153(4):1309-19. PubMed ID: 18455317
[TBL] [Abstract][Full Text] [Related]
29. Inflammation triggers constitutive activity and agonist-induced negative responses at M(3) muscarinic receptor in dental pulp.
Sterin-Borda L; Orman B; De Couto Pita A; Borda E
J Endod; 2011 Feb; 37(2):185-90. PubMed ID: 21238800
[TBL] [Abstract][Full Text] [Related]
30. Muscarinic receptor blockade in ventral hippocampus and prelimbic cortex impairs memory for socially transmitted food preference.
Carballo-Márquez A; Vale-Martínez A; Guillazo-Blanch G; Martí-Nicolovius M
Hippocampus; 2009 May; 19(5):446-55. PubMed ID: 19004013
[TBL] [Abstract][Full Text] [Related]
31. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
[TBL] [Abstract][Full Text] [Related]
32. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
Bymaster FP; Heath I; Hendrix JC; Shannon HE
J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390
[TBL] [Abstract][Full Text] [Related]
33. Xanomeline modulation of the blood oxygenation level-dependent signal in awake rats: development of pharmacological magnetic resonance imaging as a translatable pharmacodynamic biomarker for central activity and dose selection.
Baker S; Chin CL; Basso AM; Fox GB; Marek GJ; Day M
J Pharmacol Exp Ther; 2012 Apr; 341(1):263-73. PubMed ID: 22267203
[TBL] [Abstract][Full Text] [Related]
34. The cholinergic system modulates negative BOLD responses in the prefrontal cortex once electrical perforant pathway stimulation triggers neuronal afterdischarges in the hippocampus.
Arboit A; Krautwald K; Angenstein F
J Cereb Blood Flow Metab; 2022 Feb; 42(2):364-380. PubMed ID: 34590894
[TBL] [Abstract][Full Text] [Related]
35. In vivo and in vitro effects of pilocarpine: relevance to ictogenesis.
Marchi N; Oby E; Batra A; Uva L; De Curtis M; Hernandez N; Van Boxel-Dezaire A; Najm I; Janigro D
Epilepsia; 2007 Oct; 48(10):1934-46. PubMed ID: 17645533
[TBL] [Abstract][Full Text] [Related]
36. Peripheral versus central muscarinic effects on blood pressure, cardiac contractility, heart rate, and body temperature in the rat monitored by radiotelemetry.
Smith EC; Padnos B; Cordon CJ
Pharmacol Toxicol; 2001 Jul; 89(1):35-42. PubMed ID: 11484908
[TBL] [Abstract][Full Text] [Related]
37. Insular muscarinic signaling regulates anxiety-like behaviors in rats on the elevated plus-maze.
Li H; Chen L; Li P; Wang X; Zhai H
Behav Brain Res; 2014 Aug; 270():256-60. PubMed ID: 24844754
[TBL] [Abstract][Full Text] [Related]
38. Central muscarinic receptors signal pilocarpine-induced salivation.
Takakura AC; Moreira TS; Laitano SC; De Luca Júnior LA; Renzi A; Menani JV
J Dent Res; 2003 Dec; 82(12):993-7. PubMed ID: 14630901
[TBL] [Abstract][Full Text] [Related]
39. Muscarinic receptor pharmacology and circuitry for the modulation of cognition.
Bubser M; Byun N; Wood MR; Jones CK
Handb Exp Pharmacol; 2012; (208):121-66. PubMed ID: 22222698
[TBL] [Abstract][Full Text] [Related]
40. Muscarinic agonists and antagonists in schizophrenia: recent therapeutic advances and future directions.
Bolbecker AR; Shekhar A
Handb Exp Pharmacol; 2012; (208):167-90. PubMed ID: 22222699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
